|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 31, 2017 ) Respiratory diseases drugs market covers drugs that are used in the treatment of a wide range of respiratory diseases such as asthma, Chronic obstructive pulmonary disease, chronic and acute bronchitis, Emphysema and cystic fibrosis. Some of the major drugs in the market include Advair /Seretide, Avastin, Singulair, montelukast, prednisone, and azithromycin.
For more information about this report at http://www.reportsweb.com/respiratory-diseases-drugs-market-global-report-2017
The global respiratory diseases drugs market was estimated to be around $51 billion as of 2016. The respiratory diseases drugs market market made up around 5% of the overall pharmaceuticals market in 2016. The respiratory diseases drugs market was the eleventh market in the global pharmaceutical market in 2016.
Collaborations
Top competitors in the respiratory diseases drugs market are strategically partnering and collaborating with other companies to broaden their product portfolio is a major trend in this market. For instance, in March 2017, AstraZeneca announced collaboration with Circassia Pharmaceuticals plc, (a UK based respiratory biopharmaceutical company) for the development and commercialisation of Tudorza and Duaklir in the US. Tudorza and Duaklir are used in the treatment of chronic obstructive pulmonary disease (COPD).
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001890210/sample
Table of Content
1. Respiratory Diseases Drugs Market Characteristics
2. Respiratory Diseases Drugs Market Size And Growth
3. Pestle Analysis
4. Respiratory Diseases Drugs Market Customer Information
5. Respiratory Diseases Drugs Market Segmentation
6. Respiratory Diseases Drugs Market Regional And Country Analysis
7. Global Respiratory Diseases Drugs Market Comparison With Macro Economic Factors
8. Respiratory Diseases Drugs Market Comparison With Macro Economic Factors Across Countries
9. Respiratory Diseases Drugs Market Comparison With Industry Metrics
10. Asia-Pacific Respiratory Diseases Drugs Market
11. Western Europe Respiratory Diseases Drugs Market
12. Eastern Europe Respiratory Diseases Drugs Market
13. North America Respiratory Diseases Drugs Market
14. South America Respiratory Diseases Drugs Market
15. Middle East Respiratory Diseases Drugs Market
16. Africa Respiratory Diseases Drugs Market
17. Respiratory Diseases Drugs Market Competitive Landscape
18. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market
19. Market Background: Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
Companies Mentioned
Anti-Asthma And COPD Products Market, Cough And Cold Preparations
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001890210/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
